#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

A Gammaherpesvirus Cooperates with Interferon-alpha/beta-Induced IRF2 to Halt Viral Replication, Control Reactivation, and Minimize Host Lethality


The gammaherpesviruses, including Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV), establish latency in memory B lymphocytes and promote lymphoproliferative disease in immunocompromised individuals. The precise immune mechanisms that prevent gammaherpesvirus reactivation and tumorigenesis are poorly defined. Murine gammaherpesvirus 68 (MHV68) is closely related to EBV and KSHV, and type I (alpha/beta) interferons (IFNαβ) regulate MHV68 reactivation from both B cells and macrophages by unknown mechanisms. Here we demonstrate that IFNβ is highly upregulated during latent infection, in the absence of detectable MHV68 replication. We identify an interferon-stimulated response element (ISRE) in the MHV68 M2 gene promoter that is bound by the IFNαβ-induced transcriptional repressor IRF2 during latency in vivo. The M2 protein regulates B cell signaling to promote establishment of latency and reactivation. Virus lacking the M2 ISRE (ISREΔ) overexpresses M2 mRNA and displays uncontrolled acute replication in vivo, higher latent viral load, and aberrantly high reactivation from latency. These phenotypes of the ISREΔ mutant are B-cell-specific, require IRF2, and correlate with a significant increase in virulence in a model of acute viral pneumonia. We therefore identify a mechanism by which a gammaherpesvirus subverts host IFNαβ signaling in a surprisingly cooperative manner, to directly repress viral replication and reactivation and enforce latency, thereby minimizing acute host disease. Since we find ISREs 5′ to the major lymphocyte latency genes of multiple rodent, primate, and human gammaherpesviruses, we propose that cooperative subversion of IFNαβ-induced IRFs to promote latent infection is an ancient strategy that ensures a stable, minimally-pathogenic virus-host relationship.


Vyšlo v časopise: A Gammaherpesvirus Cooperates with Interferon-alpha/beta-Induced IRF2 to Halt Viral Replication, Control Reactivation, and Minimize Host Lethality. PLoS Pathog 7(11): e32767. doi:10.1371/journal.ppat.1002371
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002371

Souhrn

The gammaherpesviruses, including Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV), establish latency in memory B lymphocytes and promote lymphoproliferative disease in immunocompromised individuals. The precise immune mechanisms that prevent gammaherpesvirus reactivation and tumorigenesis are poorly defined. Murine gammaherpesvirus 68 (MHV68) is closely related to EBV and KSHV, and type I (alpha/beta) interferons (IFNαβ) regulate MHV68 reactivation from both B cells and macrophages by unknown mechanisms. Here we demonstrate that IFNβ is highly upregulated during latent infection, in the absence of detectable MHV68 replication. We identify an interferon-stimulated response element (ISRE) in the MHV68 M2 gene promoter that is bound by the IFNαβ-induced transcriptional repressor IRF2 during latency in vivo. The M2 protein regulates B cell signaling to promote establishment of latency and reactivation. Virus lacking the M2 ISRE (ISREΔ) overexpresses M2 mRNA and displays uncontrolled acute replication in vivo, higher latent viral load, and aberrantly high reactivation from latency. These phenotypes of the ISREΔ mutant are B-cell-specific, require IRF2, and correlate with a significant increase in virulence in a model of acute viral pneumonia. We therefore identify a mechanism by which a gammaherpesvirus subverts host IFNαβ signaling in a surprisingly cooperative manner, to directly repress viral replication and reactivation and enforce latency, thereby minimizing acute host disease. Since we find ISREs 5′ to the major lymphocyte latency genes of multiple rodent, primate, and human gammaherpesviruses, we propose that cooperative subversion of IFNαβ-induced IRFs to promote latent infection is an ancient strategy that ensures a stable, minimally-pathogenic virus-host relationship.


Zdroje

1. GanemD 2007 Kapsoi's Sarcoma-Associated Herpesvirus. KnipeDMHowleyPM Fields Virology 5th edition: Lippincott Williams & Wilkins 2847 2888

2. RickinsonABKieffE 2007 Epstein-Barr Virus. KnipeDMHowleyPM Fields Virology 5th ed: Lippincott Williams & Wilkins 2655 2700

3. VirginHWLatreillePWamsleyPHallsworthKWeckKE 1997 Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71 5894 5904

4. BartonEMandalPSpeckSH 2011 Pathogenesis and Host Control of Gammaherpesviruses: Lessons from the Mouse. Annu Rev of Immunol 29 351 397

5. BartonESLutzkeMLRochfordRVirginHW 2005 Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J Virol 79 14149 14160

6. HondaKTakaokaATaniguchiT 2006 Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25 349 360

7. HidaSOgasawaraKSatoKAbeMTakayanagiH 2000 CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 13 643 655

8. VandevennePSadzot-DelvauxCPietteJ 2010 Innate immune response and viral interference strategies developed by human herpesviruses. Biochem Pharmacol 80 1955 1972

9. JacobyMAVirginHWtSpeckSH 2002 Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J Virol 76 1790 1801

10. SimasJPMarquesSBridgemanAEfstathiouSAdlerH 2004 The M2 gene product of murine gammaherpesvirus 68 is required for efficient colonization of splenic follicles but is not necessary for expansion of latently infected germinal centre B cells. J Gen Virol 85 2789 2797

11. MadureiraPAMatosPSoeiroIDixonLKSimasJP 2005 Murine gamma-herpesvirus 68 latency protein M2 binds to Vav signaling proteins and inhibits B-cell receptor-induced cell cycle arrest and apoptosis in WEHI-231 B cells. J Biol Chem 280 37310 37318

12. RodriguesLPires de MirandaMCalocaMJBusteloXRSimasJP 2006 Activation of Vav by the gammaherpesvirus M2 protein contributes to the establishment of viral latency in B lymphocytes. J Virol 80 6123 6135

13. Pires de MirandaMAlenquerMMarquesSRodriguesLLopesF 2008 The Gammaherpesvirus m2 protein manipulates the Fyn/Vav pathway through a multidocking mechanism of assembly. PloS One 3 e1654

14. SpeckSHGanemD 2010 Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8 100 115

15. LiangXCollinsCMMendelJBIwakoskiNNSpeckSH 2009 Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog 5 e1000677

16. ChatterjeeMOsborneJBestettiGChangYMoorePS 2002 Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298 1432 1435

17. NingSHuyeLEPaganoJS 2005 Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit. J Virol 79 11671 11676

18. ZhangLPaganoJS 1999 Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency. Mol Cell Biol 19 3216 3223

19. LuRAuWCYeowWSHagemanNPithaPM 2000 Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation. J Biol Chem 275 31805 31812

20. DeZaliaMSpeckSH 2008 Identification of closely spaced but distinct transcription initiation sites for the murine gammaherpesvirus 68 latency-associated M2 gene. J Virol 82 7411 7421

21. HondaKTaniguchiT 2006 IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 644 658

22. HaradaHFujitaTMiyamotoMKimuraYMaruyamaM 1989 Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58 729 739

23. Weslow-SchmidtJLJewellNAMertzSESimasJPDurbinJE 2007 Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection. J Virol 81 9778 9789

24. FlanoEJiaQMooreJWoodlandDLSunR 2005 Early establishment of gamma-herpesvirus latency: implications for immune control. J Immunol 174 4972 4978

25. WeckKEBarkonMLYooLISpeckSHVirginHI 1996 Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol 70 6775 6780

26. WeckKEKimSSVirginHISpeckSH 1999 Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol 73 3273 3283

27. LeeKSCoolCDvan DykLF 2009 Murine gammaherpesvirus 68 infection of gamma interferon-deficient mice on a BALB/c background results in acute lethal pneumonia that is dependent on specific viral genes. J Virol 83 11397 11401

28. TibbettsSALohJVan BerkelVMcClellanJSJacobyMA 2003 Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J Virol 77 7696 7701

29. LiHIkutaKSixbeyJWTibbettsSA 2008 A replication-defective gammaherpesvirus efficiently establishes long-term latency in macrophages but not in B cells in vivo. J Virol 82 8500 8508

30. HadinotoVShapiroMSunCCThorley-LawsonDA 2009 The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5 e1000496

31. KhannaRSladeRWPoulsenLMossDJBurrowsSR 1997 Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J Virol 71 8340 8346

32. TakiSNakajimaSIchikawaESaitoTHidaS 2005 IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J Immunol 174 6005 6012

33. IchikawaEHidaSOmatsuYShimoyamaSTakaharaK 2004 Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2. Proc Natl Acad Sci U S A 101 3909 3914

34. LohoffMDuncanGSFerrickDMittruckerHWBischofS 2000 Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med 192 325 336

35. HaradaHKitagawaMTanakaNYamamotoHHaradaK 1993 Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259 971 974

36. PalombellaVJManiatisT 1992 Inducible processing of interferon regulatory factor-2. Mol Cell Biol 12 3325 3336

37. HanKJJiangLShuHB 2008 Regulation of IRF2 transcriptional activity by its sumoylation. Biochem Biophys Res Commun 372 772 778

38. MasumiAFukazawaHShimazuTYoshidaMOzatoK 2006 Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation. Oncogene 25 5113 5124

39. BirnbaumMJvan ZundertBVaughanPSWhitmarshAJvan WijnenAJ 1997 Phosphorylation of the oncogenic transcription factor interferon regulatory factor 2 (IRF2) in vitro and in vivo. J Cell Biochem 66 175 183

40. ChildsKSGoodbournS 2003 Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Res 31 3016 3026

41. GregorySMWestJADillonPJHilscherCDittmerDP 2009 Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A 106 11725 11730

42. GarganoLMForrestJCSpeckSH 2009 Signaling through Toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo. J Virol 83 1474 1482

43. O'NeillLAJBowieAG 2007 The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7 353 364

44. SchmitzFHeitAGuggemoosSKrugAMagesJ 2007 Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. European J Immunol 37 315 327

45. HuGManclMEBarnesBJ 2005 Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res 65 7403 7412

46. ForrestJCSpeckSH 2008 Establishment of B-Cell Lines Latently Infected with Reactivation-Competent Murine Gammaherpesvirus 68 Provides Evidence for Viral Alteration of a DNA Damage-Signaling Cascade. J Virol 82 7688 7699

47. LiangXShinYCMeansREJungJU 2004 Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein. J Virol 78 12416 12427

48. OffermannMK 2007 Kaposi sarcoma herpesvirus-encoded interferon regulator factors. Curr Top Microbiol Immunol 312 185 209

49. WiesEHahnASSchmidtKViebahnCRohlandN 2009 The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5. The J Biol Chem 284 8525 8538

50. LubyovaBKellumMJFrisanchoAJPithaPM 2004 Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 279 7643 7654

51. WiesEMoriYHahnAKremmerESturzlM 2008 The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood 111 320 327

52. NonkweloCRufIKSampleJ 1997 Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma. J Virol 71 6887 6897

53. SchaeferBCPaulsonEStromingerJLSpeckSH 1997 Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol Cell Biol 17 873 886

54. HughesDJKiparAMilliganSGCunninghamCSandersM 2010 Characterization of a novel wood mouse virus related to murid herpesvirus 4. J Gen Virol 91 867 879

55. PrestiRMPopkinDLConnickMPaetzoldSVirginHW 2001 Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages. J Exp Med 193 483 496

56. AdlerHMesserleMWagnerMKoszinowskiUH 2000 Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74 6964 6974

57. MullerUSteinhoffUReisLFHemmiSPavlovicJ 1994 Functional role of type I and type II interferons in antiviral defense. Science 264 1918 1921

58. GriederFBVogelSN 1999 Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology 257 106 118

59. LevyDE 1998 Analysis of interferon-regulated proteins binding the interferon-alpha-stimulated response element. Methods 15 167 174

60. ZhangLPaganoJS 1997 IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell Biol 17 5748 5757

61. NingSHahnAMHuyeLEPaganoJS 2003 Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. J Virol 77 9359 9368

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#